319 results Stibbe advises on the contemplated IPO of Agendia Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises on the IPO of Tornier Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. Key Insights Stibbe Equity Capital Markets Seminar 2025 On Thursday 19 June 2025, Stibbe hosted its annual Equity Capital Markets Seminar. The gathering, hosted by Pieter Schütte and Nora Offergelt, was attended by over 70 capital markets participants. ESG risk management: developments in the Dutch and EU financial sector What ESG risk rules are coming for EU/Dutch financial firms? DNB’s new climate risk Guide for insurers, pension funds, and payment firms aligns with EBA ESG Guidelines. This blog explains how both shape the future of EU ESG risk management. Pieter Schütte Partner Amsterdam Stibbe advises BP Stibbe successfully acted as counsel for BP in proceedings before the Dutch courts and the CJEU. Elvis Musema Junior Associate Brussels Chris van Es Associate Amsterdam Rogier Raas Partner Amsterdam Stibbe advises Aegon on the launch of the first General Pension Fund in the Netherlands Stibbe has made a significant contribution to the establishment of the first General Pension Fund in the Netherlands. Aegon is the first company to receive approval from the Dutch Central Bank to launch a General Pension Fund in the Netherlands. Listing Act: reversing MiFID II's unbundling regime – is it enough? The Listing Act rolls back the unbundling requirements introduced by MiFID II by once again permitting joint payments for investment research and execution services. In this article, we address the background and practical implications of this amendment. Key Insights Stibbe Capital Markets Seminar 2024 The focus of this year's annual Capital Markets Seminar, attended by over 70 capital markets participants, was on "The case for Amsterdam listings - now and in the future". Read here the key insights. Nyima Fabry Junior Associate Brussels Stibbe Equity Capital Markets Seminar On Thursday 19 June 2025, Stibbe will host its annual Equity Capital Markets seminar. This year, the seminar will discuss “The EU Savings and Investments Union – Building an Efficient European Capital Market”. Manon Cremers Partner Amsterdam Pagination Previous page Page 15 Page 16 Current page 17 Page 18 Next page
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.
Key Insights Stibbe Equity Capital Markets Seminar 2025 On Thursday 19 June 2025, Stibbe hosted its annual Equity Capital Markets Seminar. The gathering, hosted by Pieter Schütte and Nora Offergelt, was attended by over 70 capital markets participants.
ESG risk management: developments in the Dutch and EU financial sector What ESG risk rules are coming for EU/Dutch financial firms? DNB’s new climate risk Guide for insurers, pension funds, and payment firms aligns with EBA ESG Guidelines. This blog explains how both shape the future of EU ESG risk management.
Stibbe advises BP Stibbe successfully acted as counsel for BP in proceedings before the Dutch courts and the CJEU.
Stibbe advises Aegon on the launch of the first General Pension Fund in the Netherlands Stibbe has made a significant contribution to the establishment of the first General Pension Fund in the Netherlands. Aegon is the first company to receive approval from the Dutch Central Bank to launch a General Pension Fund in the Netherlands.
Listing Act: reversing MiFID II's unbundling regime – is it enough? The Listing Act rolls back the unbundling requirements introduced by MiFID II by once again permitting joint payments for investment research and execution services. In this article, we address the background and practical implications of this amendment.
Key Insights Stibbe Capital Markets Seminar 2024 The focus of this year's annual Capital Markets Seminar, attended by over 70 capital markets participants, was on "The case for Amsterdam listings - now and in the future". Read here the key insights.
Stibbe Equity Capital Markets Seminar On Thursday 19 June 2025, Stibbe will host its annual Equity Capital Markets seminar. This year, the seminar will discuss “The EU Savings and Investments Union – Building an Efficient European Capital Market”.